RQ Bio
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
$115MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
Develops superconducting quantum computers delivered via cloud for financial services, defence, and research customers
Pitching Oxford Science Enterprises? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room